Akron Biotechnology - Ownership and Business Overview

Life ScienceCompany

Akron Biotechnology Ownership

Who owns Akron Biotechnology?

Akron Biotechnology is owned by Arcline Investment Management. It was acquired on September 11, 2019.

Is Akron Biotechnology PE-backed?

Yes. Akron Biotechnology is owned by private equity investor Arcline Investment Management.

Akron Biotechnology Business Overview

Where is Akron Biotechnology headquartered?

Akron Biotechnology is headquartered in Boca Raton, Florida.

What sector is Akron Biotechnology in?

Akron Biotechnology is a life science company.

When was Akron Biotechnology founded?

Akron Biotechnology was founded in 2006.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 249 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 205 by strategics.

Akron Biotechnology

Akron Biotechnology LLC

6353 West Rogers Circle, Suite 2,
Boca Raton, Florida 33487
United States,
(561) 750-6120
www.akronbiotech.com

Akron Biotechnology is a provider of cGMP-compliant products and services critical for the production of advanced therapy medicinal products, including cell therapies, gene therapies, and engineered tissues. Akron offers a variety of cGMP products, including cytokines and growth factors, cryopreservation solutions, and cell culture media supplements. Akron Biotechnology was founded in 2006 and is based in Boca Raton, Florida.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.